Table I.
Study, year (Refs.) | No. of patients | SUVmax | SUVmax cut off | Sensitivity, % | Specificity, % | Accuracy, % | |
---|---|---|---|---|---|---|---|
| |||||||
Benign | Malignant | ||||||
Fuglø 2012 (9) | 89 | 95.8 | 92.7 | 93.1 | |||
Aoki 2003 (5) | 114 | 1.80 (SD, ±1.42) | 4.20 (SD, ±3.16) | ||||
Shin 2008 (10) | 34 | 2.9 (range, 0.6–5.5) | 12.0 (range, 4.3–45.7) | 4.7 | 89.6 | 86.7 | 88.2 |
Piperkova 2008 (11) | 93 | 100 | 95.9 | ||||
Charest 2009 (6) | 212 | 93.9 | |||||
Iagaru 2006 (12) | 44 | 100 | 93.3 | ||||
Strobel (13) | 50 | 3.5 (range, 1.6–8.0) | 3.5 ( 1.6–8.0) (range, 1.6–8.0) | 91 | 77 | 86 | |
Shin 2008 (14) | 87 | 5.1 | 8.8 | 4.7 | 80 | 63 | 70 |
Eary 2002 (15) | 209 | 6 (range, 3.8–11.3) |
SD, standard deviation; SUVmax, maximum standardized uptake volume.